TWMP
Taylor Wealth Management Partners Portfolio holdings
AUM
$176M
This Quarter Return
+17.45%
1 Year Return
-14.65%
3 Year Return
+61.88%
5 Year Return
+170.69%
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(+19%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
45.88%
Holding
65
New
11
Increased
19
Reduced
30
Closed
1
Top Buys
| 1 |
Bank of America
BAC
|
$4.63M |
| 2 |
Shift4
FOUR
|
$3.25M |
| 3 |
Envista
NVST
|
$3.01M |
| 4 |
Vistra
VST
|
$1.77M |
| 5 |
Ameresco
AMRC
|
$1.53M |
Top Sells
| 1 |
PayPal
PYPL
|
$900K |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$748K |
| 3 |
CVS Health
CVS
|
$580K |
| 4 |
RTX Corp
RTX
|
$379K |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$308K |
Sector Composition
| 1 | Technology | 32.1% |
| 2 | Healthcare | 15.92% |
| 3 | Industrials | 15.3% |
| 4 | Financials | 12.57% |
| 5 | Communication Services | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.98M | 1.53% |
30,634
+6
| +0% | +$780 |
|
27
Halozyme
HALO
$8.56B
| $3.8M | 1.46% |
88,941
+2,085
| +2% | +$89.1K |
|
|
PROF
28
Profound Medical
PROF
$134M
| $3.42M | 1.31% |
166,294
-70
| -0% | -$1.44K |
|
29
McDonald's
MCD
$224B
| $3.33M | 1.28% |
15,516
-384
| -2% | -$82.4K |
|
|
30
Shift4
FOUR
$6.21B
| $3.25M | 1.25% |
+43,109
| New | +$3.25M |
|
31
Zymeworks
ZYME
$1.12B
| $3.24M | 1.25% |
68,550
-301
| -0.4% | -$14.2K |
|
|
32
RTX Corp
RTX
$212B
| $3.08M | 1.18% |
43,013
-5,301
| -11% | -$379K |
|
|
33
Envista
NVST
$3.52B
| $3.01M | 1.16% |
+89,270
| New | +$3.01M |
|
|
PING
34
DELISTED
Ping Identity Holding Corp.
PING
| $3.01M | 1.16% |
105,079
+691
| +0.7% | +$19.8K |
|
35
Autodesk
ADSK
$67.3B
| $3M | 1.16% |
9,837
+20
| +0.2% | +$6.11K |
|
|
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.79M | 1.07% |
64,321
+11,724
| +22% | +$508K |
|
37
IBEX
IBEX
$395M
| $2.54M | 0.98% |
135,650
+3,825
| +3% | +$71.5K |
|
38
Truist Financial
TFC
$60.4B
| $2.35M | 0.9% |
48,961
-6,341
| -11% | -$304K |
|
39
Sandstorm Gold
SAND
$3.27B
| $2.21M | 0.85% |
307,480
-9,850
| -3% | -$70.6K |
|
40
Transmedics
TMDX
$3.92B
| $1.62M | 0.62% |
81,595
+498
| +0.6% | +$9.91K |
|
|
41
Ameresco
AMRC
$1.34B
| $1.53M | 0.59% |
+29,274
| New | +$1.53M |
|
42
OptimizeRx
OPRX
$335M
| $890K | 0.34% |
28,555
-1,565
| -5% | -$48.8K |
|
|
EVFM
43
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $862K | 0.33% |
357,580
-127,790
| -26% | -$308K |
|
|
MMX
44
DELISTED
Maverix Metals Inc. Common Shares
MMX
| $813K | 0.31% |
148,843
-1,045
| -0.7% | -$5.71K |
|
|
GRTX
45
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $662K | 0.25% |
64,753
+2,582
| +4% | +$26.4K |
|
46
Krystal Biotech
KRYS
$4.27B
| $347K | 0.13% |
+5,778
| New | +$347K |
|
47
Vertex Pharmaceuticals
VRTX
$100B
| $322K | 0.12% |
1,363
+311
| +30% | +$73.5K |
|
48
Viatris
VTRS
$12.3B
| $302K | 0.12% |
+16,133
| New | +$302K |
|
49
Thermo Fisher Scientific
TMO
$186B
| $297K | 0.11% |
+637
| New | +$297K |
|
|
RCM
50
DELISTED
R1 RCM Inc. Common Stock
RCM
| $265K | 0.1% |
+11,025
| New | +$265K |
|